- Investing Ideas
- South Korean Pharmaceuticals & Biotech Healthy potentially undervalued
South Korean Pharmaceuticals & Biotech Healthy potentially undervalued
Results
6
Companies which are potentially undervalued and in an acceptable financial position.
6 companies
Dong-A Socio Holdings
Market Cap: ₩562.1b
Engages in the pharmaceutical business in South Korea.
A000640
₩84,800.00
7D
5.0%
1Y
-26.4%
Hugel
Market Cap: ₩2.7t
Develops and manufactures biopharmaceuticals in South Korea and internationally.
A145020
₩248,000.00
7D
8.8%
1Y
-32.5%
Dong-A ST
Market Cap: ₩349.9b
Develops, manufactures, and markets pharmaceutical products in South Korea and internationally.
A170900
₩36,400.00
7D
2.2%
1Y
-19.3%
Daewoong Pharmaceutical
Market Cap: ₩1.4t
Develops, manufactures and commercializes pharmaceutical products in South Korea and internationally.
A069620
₩120,200.00
7D
0.6%
1Y
-23.9%
PharmaResearch
Market Cap: ₩3.2t
Operates as a biopharmaceutical company primarily in South Korea.
A214450
₩303,500.00
7D
17.2%
1Y
-33.7%
ST PharmLtd
Market Cap: ₩2.6t
Provides manufacturing services for active pharmaceutical ingredient and intermediate.
A237690
₩123,800.00
7D
13.1%
1Y
54.9%